News Coverage 06.08.22 Share on Twitter Share on Facebook Share on LinkedIn Why these cancer immunotherapy experts are leaning into a five-year deal Related Announcement, Partner Highlight, Press Release Alliance Aims to Develop Next-Gen Cancer Therapies Announcement PICI Hosts 2024 Spring Scientific Retreat Press Release BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
Press Release BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes